These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32747510)

  • 1. Appropriate Use Criteria for PET Myocardial Perfusion Imaging.
    Schindler TH; Bateman TM; Berman DS; Chareonthaitawee P; De Blanche LE; Dilsizian V; Dorbala S; Gropler RJ; Shaw L; Soman P; Winchester DE; Verberne H; Ahuja S; Beanlands RS; Di Carli MF; Murthy VL; Ruddy TD; Schwartz RG
    J Nucl Med; 2020 Aug; 61(8):1221-1265. PubMed ID: 32747510
    [No Abstract]   [Full Text] [Related]  

  • 2. Measuring myocardial perfusion: the role of PET, MRI and CT.
    Qayyum AA; Kastrup J
    Clin Radiol; 2015 Jun; 70(6):576-84. PubMed ID: 25649865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-centered imaging.
    Depuey EG; Mahmarian JJ; Miller TD; Einstein AJ; Hansen CL; Holly TA; Miller EJ; Polk DM; Samuel Wann L
    J Nucl Cardiol; 2012 Apr; 19(2):185-215. PubMed ID: 22328324
    [No Abstract]   [Full Text] [Related]  

  • 4. Transient ischemic dilation ratio in 82Rb PET myocardial perfusion imaging: normal values and significance as a diagnostic and prognostic marker.
    Rischpler C; Higuchi T; Fukushima K; Javadi MS; Merrill J; Nekolla SG; Bravo PE; Bengel FM
    J Nucl Med; 2012 May; 53(5):723-30. PubMed ID: 22492731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of myocardial perfusion and viability by positron emission tomography.
    Anagnostopoulos C; Georgakopoulos A; Pianou N; Nekolla SG
    Int J Cardiol; 2013 Sep; 167(5):1737-49. PubMed ID: 23313467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myocardial viability imaging in ischaemic heart disease, part 2: current role of radionuclide imaging. Expert consensus statement of the Polish Clinical Forum for Cardiovascular Imaging].
    Płońska Gościniak E; Kostkiewicz M; Pasowicz M; Miszalski Jamka T; Szyszka A; Lipiec P; Gackowski A; Kukulski T; Dziuk M; Kępka C; Skowerski M; Gąsior Z; Walecki J; Szymański P; Mizia Stec K; Klisiewicz A; Hoffman P; Podolec P; Pruszczyk P; Kasprzak JD;
    Kardiol Pol; 2012; 70(8):857-65. PubMed ID: 22933225
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac PET: a versatile, quantitative measurement tool for heart failure management.
    Gewirtz H
    JACC Cardiovasc Imaging; 2011 Mar; 4(3):292-302. PubMed ID: 21414579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quality control of PET imaging: from study to diagnosis].
    Daisaki H
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2012; 68(7):916-25. PubMed ID: 22821167
    [No Abstract]   [Full Text] [Related]  

  • 9. Integrated Myocardial Perfusion Imaging Diagnostics Improve Detection of Functionally Significant Coronary Artery Stenosis by 13N-ammonia Positron Emission Tomography.
    Lee JM; Kim CH; Koo BK; Hwang D; Park J; Zhang J; Tong Y; Jeon KH; Bang JI; Suh M; Paeng JC; Cheon GJ; Na SH; Ahn JM; Park SJ; Kim HS
    Circ Cardiovasc Imaging; 2016 Sep; 9(9):. PubMed ID: 27609817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of sex on risk stratification with stress myocardial perfusion Rb-82 positron emission tomography: Results from the PET (Positron Emission Tomography) Prognosis Multicenter Registry.
    Kay J; Dorbala S; Goyal A; Fazel R; Di Carli MF; Einstein AJ; Beanlands RS; Merhige ME; Williams BA; Veledar E; Chow BJ; Min JK; Berman DS; Shah S; Bellam N; Butler J; Shaw LJ
    J Am Coll Cardiol; 2013 Nov; 62(20):1866-76. PubMed ID: 23850903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial perfusion imaging with PET.
    Driessen RS; Raijmakers PG; Stuijfzand WJ; Knaapen P
    Int J Cardiovasc Imaging; 2017 Jul; 33(7):1021-1031. PubMed ID: 28188475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of myocardial perfusion using cardiac magnetic resonance imaging correlates significantly to rubidium-82 positron emission tomography in patients with severe coronary artery disease: a preliminary study.
    Qayyum AA; Hasbak P; Larsson HBW; Christensen TE; Ghotbi AA; Mathiasen AB; Vejlstrup NG; Kjaer A; Kastrup J
    Eur J Radiol; 2014 Jul; 83(7):1120-1128. PubMed ID: 24815746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron Emission Tomography in the Diagnosis and Management of Coronary Artery Disease.
    Kazakauskaitė E; Žaliaduonytė-Pekšienė D; Rumbinaitė E; Keršulis J; Kulakienė I; Jurkevičius R
    Medicina (Kaunas); 2018 Jul; 54(3):. PubMed ID: 30344278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of diagnostic accuracy of stress myocardial perfusion imaging for detecting hemodynamically significant coronary artery disease between cardiac magnetic resonance and nuclear medical imaging: A meta-analysis.
    Yang K; Yu SQ; Lu MJ; Zhao SH
    Int J Cardiol; 2019 Oct; 293():278-285. PubMed ID: 31303392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moving into the next era of PET myocardial perfusion imaging: introduction of novel
    Werner RA; Chen X; Rowe SP; Lapa C; Javadi MS; Higuchi T
    Int J Cardiovasc Imaging; 2019 Mar; 35(3):569-577. PubMed ID: 30334228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are cardiologists truly better at appropriately selecting patients for stress myocardial perfusion imaging?
    Doukky R; Hayes K; Frogge N
    Int J Cardiol; 2014 Sep; 176(1):285-6. PubMed ID: 25042647
    [No Abstract]   [Full Text] [Related]  

  • 17. Rubidium-82 cardiac positron emission tomography imaging: an overview for the general cardiologist.
    Dhar R; Ananthasubramaniam K
    Cardiol Rev; 2011; 19(5):255-63. PubMed ID: 21808169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who is David and who is Goliath? There is an urgent need to improve the reference standards for estimation of myocardial infarct size.
    Katus HA; Giannitsis E
    JACC Cardiovasc Imaging; 2011 May; 4(5):534-6. PubMed ID: 21565742
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic performance of myocardial perfusion imaging with SPECT, CT and MR compared to fractional flow reserve as reference standard.
    Yang Z; Zheng H; Zhou T; Yang LF; Hu XF; Peng ZH; Jiang YZ; Li M; Sun G
    Int J Cardiol; 2015; 190():103-5. PubMed ID: 25920018
    [No Abstract]   [Full Text] [Related]  

  • 20. Semi-quantitative myocardial perfusion measured by computed tomography in patients with refractory angina: a head-to-head comparison with quantitative rubidium-82 positron emission tomography as reference.
    Qayyum AA; Kühl JT; Kjaer A; Hasbak P; Kofoed KF; Kastrup J
    Clin Physiol Funct Imaging; 2017 Sep; 37(5):481-488. PubMed ID: 26625937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.